EMJ GOLD: Pharma news, views and analysis

In this week's episode, GOLD speaks to Eugene Borukhovich, Co-Founder and COO, YourCoach.Health, about the evolving landscape of digital therapeutics. He discusses his journey into the pharmaceutical space, tips for companies looking to get into DTx and his predictions for this tech evolution over coming years. And news you might have missed showcases collaborative efforts against ebola and good news from Gilead Sciences. If you're interested in learning more about the topic areas discussed in this episode, check out the following content: The changing rhythm of digital therapeutics https://www.emg-gold.com/post/the-changing-rhythm-of-digital-therapeutics Embracing pharma's digital transformation https://www.emg-gold.com/post/embracing-pharma-s-digital-transformation Top tips for digital innovation and the future of patient centricity https://www.emg-gold.com/post/podcast-top-tips-for-digital-innovation-and-the-future-of-patient-centricity

This week, the GOLD team discusses key articles and themes from the latest magazine, drilling down into topics such as what pharma can learn from the tech giants, the industry's response to Roe v. Wade and the delicate balance of biotech success, to give listeners some exclusive context and insights on three fascinating stories affecting the industry today. If you're interested in learning more about the topic areas discussed in this episode, check out the following content: Following in the footsteps of tech giants https://www.emg-gold.com/post/following-in-the-footsteps-of-tech-giants Pharma's response to Roe v. Wade https://www.emg-gold.com/post/pharma-s-response-to-roe-v-wade Is the biotech boom on thin ice? https://www.emg-gold.com/post/is-the-biotech-boom-on-thin-ice Decentralised clinical trials: going green https://www.emg-gold.com/post/decentralised-clinical-trials-going-green

In this week's episode, GOLD speaks to Patrick Short, CEO, Sano Genetics, about the challenges and opportunities in genetic medicine today. He discusses his personal connection to tackling genetic diseases, the top reasons behind research participation hesitancy and the therapy areas in which he believes genomic testing and medicine could be most impactful. Plus, news from the World Health Summit. If you're interested in learning more about the topic areas discussed in this episode, check out the following content: Tackling the trust gap in genomic medicine https://www.emg-gold.com/post/tackling-the-trust-gap-in-genomic-medicine The rare disease disparity https://www.emg-gold.com/post/the-rare-disease-disparity Davidek Herron on embracing pharma's digital transformation https://www.emg-gold.com/post/embracing-pharma-s-digital-transformation

In this week's episode, Helena and Isabel share an interview with GOLD's next Catalyst Reshema Kemps-Polanco, Executive Vice President and US Head, Novartis Oncology. In this special extended version of the interview exclusive to the podcast, hear Reshema's story and insights in full, including the life experiences that have led her to where she is today, her ideas for tackling clinical trial recruitment gaps, why equal representation matters and so much more. If you're interested in learning more about the topic areas discussed in this episode, check out the following content: Ripples of change in R&D https://www.emg-gold.com/post/ripples-of-change-in-research-and-development Setting the stage for a more equitable future https://www.emg-gold.com/post/setting-the-stage-for-a-more-equitable-future Previous Catalyst interview with Juby Jacob-Nara https://www.emg-gold.com/post/juby-jacob-nara-on-medical-affairs

In this week's episode, Helena is joined by Paul Simms, CEO of Impatient Health, to delve deeper into GOLD's recent cover feature on reframing pharma's bad boy reputation. They chat about the current state of pharma's reputation and the influence of the media and pop culture on this, the ways in which pharma can recover and bolster its reputation, and more. And in 'news you might have missed', Helena discusses the latest global awareness campaign from Leo Pharma, the ABPI's recent survey on pharma and academia collaboration and a new Marvel comic strip features Pfizer's COVID-19 vaccination efforts in the US. If you're interested in learning more about the topic areas discussed in this episode, check out the following content: Reframing pharma's bad boy reputation https://www.emg-gold.com/post/reframing-pharma-s-bad-boy-reputation Talking to Paul Simms https://www.emg-gold.com/post/podcast-talking-to-paul-simms

In this week's episode Helena and Isabel were honoured to be joined by Rino Rappuoli, Head of External R&D and Chief Scientist at GSK Vaccines. He discusses his career inspiration and journey; his work on novel scientific concepts such as reverse vaccinology, which modern vaccines are based on; and his interest in meningitis, as well as the lasting impact of COVID-19 on the vaccine landscape, how he sees the field developing in future and what investment and innovation is needed from pharma to achieve his vision. If you're interested in learning more about the topic areas discussed in this episode, check out the following content: Keeping the spark alive in vaccine development https://www.emg-gold.com/post/keeping-the-spark-alive-in-vaccine-development GSK's Judy Stewart on vaccines https://www.emg-gold.com/post/we-ve-lost-the-focus-that-we-had-on-routine-vaccination-of-preventable-diseases The return of the vaccines https://www.emg-gold.com/post/the-return-of-the-vaccines Is mRNA the future of vaccine technology? https://www.emg-gold.com/_files/ugd/b8a9db_63ca75dce7a64cd39b356ac1ffb18358.pdf

[Yesterday 15:46] Helena Beer Top tips for digital innovation and the future of patient centricity In this week's episode of The GOLD Podcast, Helena is joined by Konrad Dobschuetz, National Director at NHS Innovation Accelerator and Chief Enterprise Officer at UCL Partners, who discusses all things digital innovation. They chat about his transition from the fashion industry to pharma, some digital innovation top tips for companies and his new role at the NHS and the importance of collaboration, plus his take on how the humble automobile may someday turn into a diagnostic tool. And in 'news you might have missed', Helena discusses the latest from Boehringer Ingelheim, Sanofi and GSK. If you're interested in learning more about the topic areas discussed in this episode, check out the following content: Meet GOLD's catalyst - digital innovator, Davidek Herron: https://www.emg-gold.com/post/podcast-catalyst-digital-innovator-davidek-herron Digitalisation: moving past paperless: https://www.emg-gold.com/post/digitalisation-moving-past-paperless Reframing pharma's bad boy reputation https://www.emg-gold.com/post/reframing-pharma-s-bad-boy-reputation Taking a bet on blockchain https://www.emg-gold.com/post/taking-a-bet-on-blockchain

This week's episode features a fascinating conversation with Samin Saeed, UK Chief Scientific Officer and Medical Director at Novartis UK. She discusses a whole host of medical affairs-related issues, including the transition from medicine to pharma, cross-functionality, commercial versus medical affairs, and lots more besides, including a fascinating discussion about leadership, company culture and soft skills development. And 'news you might have missed' focuses on the European life sciences gender pay gap and new investment for Novartis. If you're interested in learning more about the topic areas discussed in this episode, check out the following content: Preparing MSLs for the spotlight https://www.emg-gold.com/post/preparing-msls-for-the-spotlight Juby Jacob-Nara on medical affairs https://www.emg-gold.com/post/juby-jacob-nara-on-medical-affairs Aliya Omer on gender equality https://www.emg-gold.com/post/podcast-aliya-omer-on-gender-equality Reframing pharma's bad boy reputation https://www.emg-gold.com/post/reframing-pharma-s-bad-boy-reputation Elevating pharma's parental leave policies https://www.emg-gold.com/post/elevating-pharma-s-parental-leave-policies

This week, Marc and Helena are joined in the podcast studio by Pav Rishiraj, Director and Head of Pharmacovigilance at Ipsen, to shed some light on this often-overlooked field of pharma. He discusses his career journey in pharmacovigilance and how, in his experience, the field has changed; the importance of pharmacovigilance as a strategic enabler within businesses; and the outlook for the future of the field in terms of AI and automation. Helena also leads a short tribute to Her Majesty Queen Elizabeth II. If you're interested in learning more about the topic areas discussed in this episode, check out the following content: The physics of pharmacovigilance https://www.emg-gold.com/post/the-physics-of-pharmacovigilance RWE, the metrics of medical affairs and TikTok marketing https://www.emg-gold.com/post/podcast-real-world-evidence-the-metrics-of-medical-affairs-and-tiktok-marketing

It's good to be back! To celebrate the launch of Season 3 of The GOLD Podcast, Marc and Helena bring you a special extended version of our conversation with GOLD's latest catalyst interviewee Dr Juby Jacob-Nara, Vice President and Global Medical Head for Respiratory, Allergy and Gastro-Intestinal Diseases, Sanofi. She speaks to Assistant Editor Isabel O'Brien about her move from medicine to medical affairs, her passion for cross-functional learning and how former physicians can empower themselves to succeed in the pharmaceutical industry. If you're interested in learning more about the topic areas discussed in this episode, check out the following content: Dr Juby Jacob-Nara on making it medical affairs https://www.emg-gold.com/post/juby-jacob-nara-on-medical-affairs Preparing MSLs for the spotlight https://www.emg-gold.com/post/preparing-msls-for-the-spotlight Luca Dezzani and Luisa Luciani-Silverman on medical affairs https://www.emg-gold.com/post/podcast-luca-dezzani-and-luisa-luciani-silverman-on-medical-affairs Medical affairs evolution and the future for MSLs https://www.emg-gold.com/post/podcast-medical-affairs-evolution-and-the-future-for-msls RWE, the metrics of medical affairs and TikTok marketing https://www.emg-gold.com/post/podcast-real-world-evidence-the-metrics-of-medical-affairs-and-tiktok-marketing